Soluble urokinase plasminogen activation receptor-An emerging new biomarker of cardiovascular disease and critical illness

Nicole Cyrille; Pedro Villablanca; Harish Ramakrishna

doi:10.4103/0971-9784.179588

Soluble urokinase plasminogen activation receptor-An emerging new biomarker of cardiovascular disease and critical illness

Nicole Cyrille, Pedro Villablanca, Harish Ramakrishna

Anesthesiology

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Soluble urokinase plasminogen activation receptor (suPAR) is an emerging new biomarker, which has been shown to not only correlate with traditional biomarkers but also outperform CRP at prognosticating CVD. More clinical trials on suPAR is in the future research agenda.

Original language	English (US)
Pages (from-to)	214-216
Number of pages	3
Journal	Annals of cardiac anaesthesia
Volume	19
Issue number	2
DOIs	https://doi.org/10.4103/0971-9784.179588
State	Published - Apr 1 2016

Keywords

Biomarkers
Cardiovascular disease
Critical illness
Heart failure

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Anesthesiology and Pain Medicine

Access to Document

10.4103/0971-9784.179588

Cite this

@article{3685bbbe4c0b433d9b1b694e70e38452,

title = "Soluble urokinase plasminogen activation receptor-An emerging new biomarker of cardiovascular disease and critical illness",

abstract = "Soluble urokinase plasminogen activation receptor (suPAR) is an emerging new biomarker, which has been shown to not only correlate with traditional biomarkers but also outperform CRP at prognosticating CVD. More clinical trials on suPAR is in the future research agenda.",

keywords = "Biomarkers, Cardiovascular disease, Critical illness, Heart failure",

author = "Nicole Cyrille and Pedro Villablanca and Harish Ramakrishna",

note = "Publisher Copyright: {\textcopyright} 2016 Annals of Cardiac Anaesthesia.",

year = "2016",

month = apr,

day = "1",

doi = "10.4103/0971-9784.179588",

language = "English (US)",

volume = "19",

pages = "214--216",

journal = "Annals of cardiac anaesthesia",

issn = "0971-9784",

publisher = "Medknow Publications and Media Pvt. Ltd",

number = "2",

}

TY - JOUR

T1 - Soluble urokinase plasminogen activation receptor-An emerging new biomarker of cardiovascular disease and critical illness

AU - Cyrille, Nicole

AU - Villablanca, Pedro

AU - Ramakrishna, Harish

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Soluble urokinase plasminogen activation receptor (suPAR) is an emerging new biomarker, which has been shown to not only correlate with traditional biomarkers but also outperform CRP at prognosticating CVD. More clinical trials on suPAR is in the future research agenda.

AB - Soluble urokinase plasminogen activation receptor (suPAR) is an emerging new biomarker, which has been shown to not only correlate with traditional biomarkers but also outperform CRP at prognosticating CVD. More clinical trials on suPAR is in the future research agenda.

KW - Biomarkers

KW - Cardiovascular disease

KW - Critical illness

KW - Heart failure

UR - http://www.scopus.com/inward/record.url?scp=84964826452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964826452&partnerID=8YFLogxK

U2 - 10.4103/0971-9784.179588

DO - 10.4103/0971-9784.179588

M3 - Article

C2 - 27052059

AN - SCOPUS:84964826452

SN - 0971-9784

VL - 19

SP - 214

EP - 216

JO - Annals of cardiac anaesthesia

JF - Annals of cardiac anaesthesia

IS - 2

ER -

Soluble urokinase plasminogen activation receptor-An emerging new biomarker of cardiovascular disease and critical illness

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this